Bcl-2 Antisense Oligonucleotides (G3139) Inhibit Merkel Cell Carcinoma Growth in SCID Mice
- 1 April 2000
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 114 (4), 725-730
- https://doi.org/10.1046/j.1523-1747.2000.00937.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Merkel cell carcinoma: Report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivityJournal of the American Academy of Dermatology, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Expression of bcl-2 and p53 in Merkel Cell CarcinomaThe American Journal of Dermatopathology, 1996
- Differences of bcl‐2 protein expression between Merkel cells and Merkel cell carcinomasJournal of Cutaneous Pathology, 1996
- Merkel cells and Merkel cell carcinoma express the BCL‐2 proto‐oncogeneExperimental Dermatology, 1996
- The state of the art in antisense researchNature Medicine, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Merkel cell carcinomaJournal of the American Academy of Dermatology, 1993
- Neuroendocrine (Merkel Cell) Carcinoma of the SkinAnnals of Surgery, 1988
- A severe combined immunodeficiency mutation in the mouseNature, 1983